In the News
Complex analytical workflows increasingly require robust bioassays
Catherine Liloia and Benjamin Ziehr comment on the crucial role bioassays play in biologic drug development.
The 2023 PharmaVoice Year in Preview
Lisa Dyment and Lloryn Hubbard weigh in on key areas of industry focus, including patient engagement and clinical trial diversity, for 2023.
The value of predictive analytical applications as digital health tools
Thomas Healy discusses the emerging benefits and capabilities of predictive analytic applications supported by wearable sensor devices.
Enabling digital and decentralized solutions in clinical research
In this article, Kamilla Posselt outlines the importance of embedding digital and decentralized solutions during early trial development.
Functional service partnerships: Speeding seamless implementation
Lisa Beckel discusses keys to implementing an FSP partnership, addressing some of the challenges, and how to assure efficient onboarding and resourcing for FSP clinical research projects.
Strategies for 21st Century Patient Recruitment
The authors examine emerging trends in patient recruitment and how best to optimize them.
AI in unexpected places: How ML and NLP improve startup timelines
The authors discuss how new applications of machine learning and natural language processing are having a profound impact on clinical trial agility and accuracy.
Thermo Fisher continues to expand clinical research capacity with $59m lab expansion
The current 71,600-square-foot operation will grow to 114,000 square feet and be completed in stages by the end of 2024, creating 200 new jobs over the next five years.
Thermo Fisher Scientific to invest $59 million with Campbell Co. expansion
Much of the expansion involves adding to the business’ sample management and testing capacity to support new therapeutics, including vaccines and cell and gene therapy products.
